Marketing drugs and devices to clinicians affects their prescribing behaviors, drives up health care costs, and increases risk of harm to patients. This article canvasses what clinicians and health professions students should know about undue influence of drug and device marketing on their practices. It also considers policy changes that would better protect patients and better situate clinicians to care for patients and communities in ways that are ethical, safe, and effective.
CITATION STYLE
Erdek, M. A. (2020). Medical education: What clinicians and health professions students should learn about how pharmaceutical marketing influences opioid prescribing and patient outcomes. AMA Journal of Ethics, 22(8), 681–686. https://doi.org/10.1001/amajethics.2020.681
Mendeley helps you to discover research relevant for your work.